Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03440411 · OUTCOME

Overall Survival

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment · Source last updated 2021-03-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
57 months

What was measured

defined as the time from the date of random disclosure to the date of death from any cause for the comparisons II vs I

Analysis population: This analysis included only patients in whom CPd vs Pd randomization was disclosed.

Groups in this outcome

Arm I

Early Treatment

Arm II

Late treatment

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I5
Arm II3

Reported measurements

Source class 1

Death

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I1Not reportedNot reportedNot reportedNot reported
Arm II1Not reportedNot reportedNot reportedNot reported

Censored

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I4Not reportedNot reportedNot reportedNot reported
Arm II2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      2. group Id
        OG001
        value
        1
      title
      Death
    2. measurements
      1. group Id
        OG000
        value
        4
      2. group Id
        OG001
        value
        2
      title
      Censored
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    2. group Id
      OG001
      value
      3
    units
    Participants
description
defined as the time from the date of random disclosure to the date of death from any cause for the comparisons II vs I
groups
  1. description
    Early Treatment
    id
    OG000
    title
    Arm I
  2. description
    Late treatment
    id
    OG001
    title
    Arm II
param Type
COUNT_OF_PARTICIPANTS
population Description
This analysis included only patients in whom CPd vs Pd randomization was disclosed.
reporting Status
POSTED
time Frame
57 months
title
Overall Survival
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice